U.S. health department hands over Medicaid personal data to ICE
Giving ICE access to the personal data of Medicaid enrollees marks an escalation in U.S. President Donald Trump's hard-line immigration policies. It may also raise privacy concerns under the Health Insurance Portability and Accountability Act, known as HIPAA.
A Department of Health and Human Services spokesperson said sharing data between the Centers for Medicare and Medicaid Services (CMS) and the Department of Homeland Security (DHS), which oversees ICE, fell within the department's legal authority.
"With respect to the recent data sharing between CMS and DHS, HHS acted entirely within its legal authority — and in full compliance with all applicable laws — to ensure that Medicaid benefits are reserved for individuals who are lawfully entitled to receive them," the spokesperson said.
A spokesperson for the Department of Homeland Security said the department was exploring an initiative with CMS to ensure people living in the country illegally do not receive Medicaid benefits.
The agreement was first reported earlier on Thursday by the Associated Press, which said it was signed on Monday.
The Medicaid health program for low income people is jointly funded by the federal government and states.
Immigrants who are in the U.S. illegally are not eligible for Medicaid under federal law, but 14 states and the District of Columbia provide coverage for eligible children regardless of immigration status, and seven states and the district do so for adults.
"CMS is aggressively cracking down on states that may be misusing federal Medicaid funds to subsidize care for illegal immigrants. This oversight effort — supported by lawful interagency data sharing with DHS — is focused on identifying waste, fraud, and systemic abuse," the HHS spokesperson said.
The spokesperson did not address questions from Reuters on the type of data being shared or on how HHS would ensure HIPAA protections are upheld. The AP, citing a copy of the data sharing agreement, said the data included home addresses and ethnicities.
The agreement is the latest in a series of moves by the health department in support of the Trump administration's immigration crackdown and comes a week after it widened its interpretation of a law banning most immigrants from receiving federal public benefits.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Japan Times
2 days ago
- Japan Times
U.S.-funded contraceptives for poor nations to be burned in France: sources
U.S.-funded contraceptives worth nearly $10 million are being sent to France from Belgium to be incinerated after Washington rejected offers from the United Nations and family planning organizations to buy or ship the supplies to poor nations, according to two sources. A spokesperson for the U.S. State Department confirmed on Wednesday that a decision had been taken to destroy the stock. The supplies have been stuck for months in a warehouse in Geel, a city in the Belgian province of Antwerp, following U.S. President Donald Trump's decision to freeze U.S. foreign aid in January. They comprise contraceptive implants and pills as well as intrauterine devices to help prevent unwanted pregnancies, according to seven sources and a screenshot shared by an eighth source confirming the planned destruction. The U.S. government will spend $167,000 to incinerate the stocks at a facility in France that handles medical waste, the U.S. State Department confirmed. The spokesperson said that a preliminary decision had been made to destroy certain products from terminated U.S. Agency for International Development (USAID) contracts. "Only a limited number of commodities have been approved for disposal," the spokesperson said via email, adding that no condoms or HIV medications would be destroyed. U.S. lawmakers have introduced two bills this month to prevent the destruction of the supplies following Trump's decision to shut down USAID, but aid groups say the bills are unlikely to be passed in time to stop the incineration. The Belgian foreign ministry said Brussels had held talks with U.S. authorities and "explored all possible options to prevent the destruction, including temporary relocation." "Despite these efforts, and with full respect for our partners, no viable alternative could be secured. Nevertheless, Belgium continues to actively seek solutions to avoid this regrettable outcome," it said in a statement on Tuesday. "Sexual and reproductive health must not be subject to ideological constraints," it added. The supplies, worth $9.7 million, are due to expire between April 2027 and September 2031, according to an internal document listing the warehouse stocks and verified by three sources. Sarah Shaw, Associate Director of Advocacy at MSI Reproductive Choices, said the nongovernmental organization had volunteered to pay for the supplies to be repackaged without USAID branding and shipped to countries in need, but the offer was declined by the U.S. government. "MSI offered to pay for repackaging, shipping and import duties but they were not open to that. ... We were told that the U.S. government would only sell the supplies at the full market value," said Shaw. She did not elaborate on how much the NGO was prepared to pay, but said she felt the rejection was based on the Trump's administration's more restrictive stance on abortion and family planning. "This is clearly not about saving money. It feels more like an ideological assault on reproductive rights, and one that is already harming women." She added that many countries in sub-Saharan Africa had relied on USAID for access to contraception and that the aid cuts would lead to a rise in unsafe abortions. The United Nations' sexual and reproductive health agency, UNFPA, also offered to buy the contraceptives outright, three sources said, without disclosing the financial terms of the proposal. However, negotiations broke down, a source with knowledge of the talks said, in part due to a lack of response from the U.S. government. UNFPA declined to comment. One of the sources with knowledge of the issue said that the Trump administration was acting in accordance with the Mexico City Policy, an anti-abortion pact in which Trump reinstated U.S. participation in January. The pact forbids the U.S. government from contributing to or working with organizations providing funding or supplies that offer access to abortions. The source said there was no way for the U.S. government to ensure that UNFPA would not share the contraceptives with groups offering abortions, violating the Mexico City Policy. The State Department also said these were factors in their decision on Wednesday, and added that it had avoided $34.1 million in costs by cancelling other orders placed under the administration of former U.S. President Joe Biden. The source also said the matter was complicated by the fact that the contraceptives in Belgium were embossed with the USAID trademark and Washington did not want any USAID-branded supplies to be rerouted elsewhere. UNFPA did not immediately respond to requests for comment on the concerns raised by the source. One of the two sources who revealed that the stocks of contraceptives were being trucked to France said it would likely take dozens of truckloads and at least two weeks to move the supplies out of the Geel warehouse, with a third source also confirming the scale of the operation. The French government did not immediately respond to requests for comment. Chemonics, the contractor managing the supply chain for USAID's family planning program, declined to comment on the plans to destroy the supplies.
NHK
5 days ago
- NHK
Researchers: Delayed treatment of bird flu may raise risk of drug-resistance
A group of researchers says delayed treatment of a type of bird flu now spreading on dairy farms in the United States may increase the virus's drug-resistance. The group is led by Professor Kawaoka Yoshihiro of the University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center. It has been studying the highly pathogenic H5N1 avian influenza virus that has spread rapidly among US dairy cattle since early 2024. There have been reports that the virus appears to have been transmitted from cows to humans in 41 cases. The researchers gave the antiviral drug Xofluza, or baloxavir marboxil, to mice infected with bovine H5N1 virus and examined its efficacy. They say that of the five mice treated with Xofluza from 24 hours after infection, three died within 21 days. They say a Xofluza-resistant virus was found in one dead mouse. The researchers say all five mice that were given Xofluza from 48 hours after infection died. Three of them reportedly had drug-resistant viruses. But the group says none of the mice given the drug starting one hour after infection died, and no drug-resistant viruses were found in them. Professor Kawaoka says there is a possibility that the virus multiplies so quickly that the emergence of drug-resistance might be facilitated. He says there is need to explore ways to respond, such as extending the period of drug administration and increasing dosage, in case humans are infected.
NHK
18-07-2025
- NHK
Trump diagnosed with venous insufficiency, but not serious health problem
0The White House says US President Donald Trump has received a medical checkup, and that he has venous insufficiency, but remains in "excellent health." In a news conference Thursday, Press Secretary Karoline Leavitt said Trump was diagnosed with chronic venous insufficiency. Leavitt said he underwent a comprehensive examination after noticing swelling in his lower legs in recent weeks. She said the condition is common in individuals over the age of 70. Trump turned 79 in June. Leavitt also said Trump's bruises on the back of his hand was caused by frequent handshaking, and the use of aspirin, which he takes for prevention against cardiovascular disease. She said the exam results showed "no signs of heart failure, renal impairment or systemic illness." Leavitt also released the physician's memorandum of the diagnosis. She said, "The President remains in excellent health, which I think all of you witness on a daily basis here." She stressed that Trump wanted to release the memorandum "in the effort of transparency." Former US President Joe Biden, who was 78 when he was sworn in, announced in May that he has been diagnosed with prostate cancer, which had spread to his bones. But Trump questioned the timing of the announcement as it was made after Biden had already left office.
